Evaluation of the efficacy of vaginal product based on chamomile for the treatment of dyspareunia
Early Phase 1
Recruiting
- Conditions
- Dyspareunia.Dyspareunia
- Registration Number
- IRCT201702197511N3
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 92
Inclusion Criteria
Patients aged 18 to 49 years old married women with dyspareunia at least during the 3 last months; having intercourse at least once during a month; conscious informed consent; normal gynecological examination; using non-hormonal contraceptives. Exclusion criteria: use of hormonal drugs, anti-hypertensive and anti-depressant drugs over a month before beginning of the study; pregnancy; breast-feeding; Menopause.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain during intercourse. Timepoint: before & after the study. Method of measurement: VAS Questionnaire.
- Secondary Outcome Measures
Name Time Method ubrication of vagina during intercourse. Timepoint: before & after the study. Method of measurement: FSFI questionnaire.;Arousal during intercourse. Timepoint: before & after the study. Method of measurement: FSFI questionnaire.;Desire during intercourse. Timepoint: before & after the study. Method of measurement: FSFI questionnaire.;Orgasm during intercourse. Timepoint: before & after the study. Method of measurement: FSFI questionnaire.;Satisfaction during intercourse. Timepoint: before & after the study. Method of measurement: FSFI questionnaire.